Item Type | Name |
Concept
|
Abnormalities, Drug-Induced
|
Concept
|
Acetaminophen
|
Concept
|
Acetyltransferases
|
Concept
|
Adrenal Cortex Hormones
|
Concept
|
Adrenergic beta-Antagonists
|
Concept
|
Alcohol Dehydrogenase
|
Concept
|
Aldehyde Dehydrogenase
|
Concept
|
Alkynes
|
Concept
|
Amines
|
Concept
|
Aminobiphenyl Compounds
|
Concept
|
Amitriptyline
|
Concept
|
Central Nervous System Stimulants
|
Concept
|
Analgesics, Opioid
|
Concept
|
Androgens
|
Concept
|
Anti-Arrhythmia Agents
|
Concept
|
Anti-Infective Agents, Local
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
Concept
|
Anti-Ulcer Agents
|
Concept
|
Antibodies
|
Concept
|
Anticoagulants
|
Concept
|
Anticonvulsants
|
Concept
|
Antidepressive Agents
|
Concept
|
Antidepressive Agents, Tricyclic
|
Concept
|
Antiemetics
|
Concept
|
Antifibrinolytic Agents
|
Concept
|
Epitopes
|
Concept
|
Antimalarials
|
Concept
|
Antimetabolites
|
Concept
|
Antimetabolites, Antineoplastic
|
Concept
|
Antitussive Agents
|
Concept
|
Antiviral Agents
|
Concept
|
Aryl Hydrocarbon Hydroxylases
|
Concept
|
Arylamine N-Acetyltransferase
|
Concept
|
Autoantigens
|
Concept
|
Baclofen
|
Concept
|
Base Sequence
|
Concept
|
Benzimidazoles
|
Concept
|
Binding Sites
|
Concept
|
Binding Sites, Antibody
|
Concept
|
Caffeine
|
Concept
|
Carbamazepine
|
Concept
|
Carbon Dioxide
|
Concept
|
Carbon Isotopes
|
Concept
|
Carboxy-Lyases
|
Concept
|
Carboxylic Ester Hydrolases
|
Concept
|
Carcinogens
|
Concept
|
Carrier Proteins
|
Concept
|
Catechol O-Methyltransferase
|
Concept
|
Catecholamines
|
Concept
|
Chloroquine
|
Concept
|
Clotrimazole
|
Concept
|
Codeine
|
Concept
|
Contraceptives, Oral
|
Concept
|
Crystallization
|
Concept
|
Cyclopropanes
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
Debrisoquin
|
Concept
|
Dehydroepiandrosterone
|
Concept
|
Dextromethorphan
|
Concept
|
Dextrorphan
|
Concept
|
Disulfides
|
Concept
|
DNA
|
Concept
|
DNA, Fungal
|
Concept
|
DNA, Ribosomal
|
Concept
|
Dopamine
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Drug Administration Schedule
|
Concept
|
Drug Combinations
|
Concept
|
Drug Hypersensitivity
|
Concept
|
Drug Interactions
|
Concept
|
Drug Labeling
|
Concept
|
Drug Resistance
|
Concept
|
Pharmaceutical Preparations
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Epoxide Hydrolases
|
Concept
|
Ethanolamines
|
Concept
|
Ethinyl Estradiol
|
Concept
|
Exons
|
Concept
|
Fatty Acids, Monounsaturated
|
Concept
|
Fluorenes
|
Concept
|
Fluorouracil
|
Concept
|
Fluoxetine
|
Concept
|
Fungal Proteins
|
Concept
|
Haptens
|
Concept
|
Heterocyclic Compounds
|
Concept
|
Amine Oxidase (Copper-Containing)
|
Concept
|
Histamine
|
Concept
|
HLA Antigens
|
Concept
|
Mixed Function Oxygenases
|
Concept
|
Hypnotics and Sedatives
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Indoles
|
Concept
|
Indomethacin
|
Concept
|
Insulin-Like Growth Factor I
|
Concept
|
Introns
|
Concept
|
Isoenzymes
|
Concept
|
Luciferases
|
Concept
|
Membrane Proteins
|
Concept
|
Methamphetamine
|
Concept
|
Methyltransferases
|
Concept
|
Metoprolol
|
Concept
|
Midazolam
|
Concept
|
Morphine
|
Concept
|
Muscle Relaxants, Central
|
Concept
|
NADPH-Ferrihemoprotein Reductase
|
Concept
|
Neoplasm Proteins
|
Concept
|
Nitrophenols
|
Concept
|
Norgestrel
|
Concept
|
Nuclear Proteins
|
Concept
|
Omeprazole
|
Concept
|
Oxidoreductases, N-Demethylating
|
Concept
|
Oxygenases
|
Concept
|
Aminosalicylic Acid
|
Concept
|
Peptide Fragments
|
Concept
|
Phenylethyl Alcohol
|
Concept
|
Phenols
|
Concept
|
Phenytoin
|
Concept
|
Phosphoadenosine Phosphosulfate
|
Concept
|
Phosphodiesterase Inhibitors
|
Concept
|
Pimozide
|
Concept
|
Plasmids
|
Concept
|
Platelet Aggregation Inhibitors
|
Concept
|
Drug Prescriptions
|
Concept
|
Primaquine
|
Concept
|
Prodrugs
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Propafenone
|
Concept
|
Propylamines
|
Concept
|
Proteins
|
Concept
|
Pyrimidinones
|
Concept
|
Pyrophosphatases
|
Concept
|
Recombinant Fusion Proteins
|
Concept
|
Recombinant Proteins
|
Concept
|
Reference Standards
|
Concept
|
Ribonucleosides
|
Concept
|
Rifampin
|
Concept
|
RNA
|
Concept
|
RNA, Fungal
|
Concept
|
RNA, Messenger
|
Concept
|
RNA, Ribosomal
|
Concept
|
Serotonin
|
Concept
|
Growth Hormone
|
Concept
|
Sparteine
|
Concept
|
Stereoisomerism
|
Concept
|
Steroid Hydroxylases
|
Concept
|
Sulfamethazine
|
Concept
|
Sulfates
|
Concept
|
Tamoxifen
|
Concept
|
Testosterone
|
Concept
|
Thromboxane-A Synthase
|
Concept
|
Ticlopidine
|
Concept
|
Tramadol
|
Concept
|
Antipsychotic Agents
|
Concept
|
Anti-Anxiety Agents
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Glucuronosyltransferase
|
Concept
|
Vancomycin
|
Concept
|
Vitamin K
|
Concept
|
Vitamins
|
Concept
|
Warfarin
|
Concept
|
Xanthine Oxidase
|
Concept
|
Zidovudine
|
Concept
|
HLA-B Antigens
|
Concept
|
Sulfotransferases
|
Concept
|
Arylsulfotransferase
|
Concept
|
Deoxyribonucleases, Type II Site-Specific
|
Concept
|
Xenobiotics
|
Concept
|
Citalopram
|
Concept
|
RNA Probes
|
Concept
|
Gene Library
|
Concept
|
Minor Histocompatibility Antigens
|
Concept
|
Interleukin-6
|
Concept
|
Tacrolimus
|
Concept
|
Cyclosporine
|
Concept
|
Bupropion
|
Concept
|
NAD(P)H Dehydrogenase (Quinone)
|
Concept
|
Fluvoxamine
|
Concept
|
Cyclooxygenase Inhibitors
|
Concept
|
Drug Monitoring
|
Concept
|
Pravastatin
|
Concept
|
Ondansetron
|
Concept
|
HIV Protease Inhibitors
|
Concept
|
Paroxetine
|
Concept
|
Alternative Splicing
|
Concept
|
Receptors, Opioid, mu
|
Concept
|
DNA Primers
|
Concept
|
DNA, Complementary
|
Concept
|
Gene Expression Regulation, Developmental
|
Concept
|
Antidepressive Agents, Second-Generation
|
Concept
|
Excitatory Amino Acid Antagonists
|
Concept
|
Analgesics, Non-Narcotic
|
Concept
|
Adrenergic Uptake Inhibitors
|
Concept
|
Antineoplastic Agents, Hormonal
|
Concept
|
Risperidone
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Anti-HIV Agents
|
Concept
|
Human Growth Hormone
|
Concept
|
Cytochrome P-450 CYP1A2
|
Concept
|
Cytochrome P-450 CYP2D6
|
Concept
|
Cytochrome P-450 CYP2E1
|
Concept
|
Ritonavir
|
Concept
|
Intramolecular Oxidoreductases
|
Concept
|
Simvastatin
|
Concept
|
Tandem Repeat Sequences
|
Concept
|
Natriuretic Peptide, Brain
|
Concept
|
Sertraline
|
Concept
|
3' Untranslated Regions
|
Concept
|
Glucuronides
|
Concept
|
DNA, Intergenic
|
Concept
|
Amino Acid Transport Systems
|
Concept
|
Amino Acid Transport System A
|
Concept
|
Multidrug Resistance-Associated Proteins
|
Concept
|
Organic Cation Transporter 1
|
Concept
|
Organic Anion Transporters, Sodium-Independent
|
Concept
|
Drosophila Proteins
|
Concept
|
MicroRNAs
|
Concept
|
Steroid 16-alpha-Hydroxylase
|
Concept
|
Dihydrouracil Dehydrogenase (NADP)
|
Concept
|
Carboxylesterase
|
Concept
|
Benzoxazines
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
Concept
|
Cytochrome P-450 CYP3A
|
Concept
|
Hepatocyte Nuclear Factor 4
|
Concept
|
Oseltamivir
|
Concept
|
2-Pyridinylmethylsulfinylbenzimidazoles
|
Concept
|
Proton Pump Inhibitors
|
Concept
|
Drug Dosage Calculations
|
Concept
|
Prescription Drugs
|
Concept
|
Serotonin 5-HT3 Receptor Agonists
|
Concept
|
Lopinavir
|
Concept
|
Sulfonylurea Receptors
|
Concept
|
Vitamin K Epoxide Reductases
|
Concept
|
Drug-Related Side Effects and Adverse Reactions
|
Concept
|
Cytochrome P-450 Enzyme Inhibitors
|
Concept
|
Cytochrome P-450 CYP2A6
|
Concept
|
Cytochrome P-450 CYP2D6 Inhibitors
|
Concept
|
Cytochrome P-450 CYP2B6 Inducers
|
Concept
|
Cytochrome P-450 CYP2B6
|
Concept
|
Cytochrome P-450 CYP2C8
|
Concept
|
Cytochrome P-450 CYP2C9
|
Concept
|
Cytochrome P-450 CYP2C19
|
Academic Article
|
Characterization of cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine.
|
Academic Article
|
Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
|
Academic Article
|
Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction.
|
Academic Article
|
Lack of weight-based dose dependency and intraindividual variability of omeprazole for CYP2C19 phenotyping.
|
Academic Article
|
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
|
Academic Article
|
Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail.
|
Academic Article
|
Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.
|
Academic Article
|
CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.
|
Academic Article
|
Comments on Hoskins et al. [(2005) drug metab dispos 33:1564-1565].
|
Academic Article
|
Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults.
|
Academic Article
|
Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity.
|
Academic Article
|
Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
|
Academic Article
|
Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects.
|
Academic Article
|
Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions.
|
Academic Article
|
Variability in drug metabolizing enzyme activity in HIV-infected patients.
|
Academic Article
|
Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect.
|
Academic Article
|
Genetic variants of the drug-metabolizing enzyme CYP2D6 in Puerto Rican psychiatry patients: a preliminary report and potential implications for breast cancer patients.
|
Academic Article
|
Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine.
|
Academic Article
|
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
|
Academic Article
|
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype.
|
Academic Article
|
In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4a expression.
|
Academic Article
|
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
|
Academic Article
|
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism.
|
Academic Article
|
Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
|
Academic Article
|
Regulation of microRNA expression by rifampin in human hepatocytes.
|
Academic Article
|
Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization.
|
Academic Article
|
Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy.
|
Academic Article
|
Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver.
|
Academic Article
|
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
|
Academic Article
|
In vivo characterization of CYP2D6*12, *29 and *84 using dextromethorphan as a probe drug: a case report.
|
Academic Article
|
Developmental Expression of CYP2B6: A Comprehensive Analysis of mRNA Expression, Protein Content and Bupropion Hydroxylase Activity and the Impact of Genetic Variation.
|
Academic Article
|
CYP450 genotype and pharmacogenetic association studies: a critical appraisal.
|
Academic Article
|
Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children.
|
Academic Article
|
Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes.
|
Academic Article
|
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
|
Academic Article
|
Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.
|
Academic Article
|
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
|
Academic Article
|
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
|
Academic Article
|
Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver.
|
Academic Article
|
Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy.
|
Academic Article
|
Precision medicine: does ethnicity information complement genotype-based prescribing decisions?
|
Academic Article
|
Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics.
|
Academic Article
|
Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex.
|
Academic Article
|
Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping.
|
Academic Article
|
Interethnic differences of drug-metabolizing enzymes.
|
Academic Article
|
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
|
Academic Article
|
Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity.
|
Academic Article
|
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.
|
Academic Article
|
The Case for Pharmacogenetics-Guided Prescribing of Codeine in Children.
|
Academic Article
|
Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism.
|
Academic Article
|
Pharmacogenetics: Chasing Perfection.
|
Grant
|
PBPK prediction of ontogeny mediated alteration in hepatic drug elimination
|
Grant
|
Research Fellowship Program in Pediatric Clinical/Developmental Pharmacology
|
Grant
|
Ontogeny of Drug Bioactivation and Idiosyncratic ADRs
|
Grant
|
Regulation of drug metabolizing enzymes by miRNAs
|
Grant
|
Research Fellowship Program in Pediatric Clinical/Developmental Pharmacology
|
Grant
|
Regulation of drug metabolizing enzymes by miRNAs
|
Academic Article
|
CRC Press/Taylor & Francis Group, Ye, S.Q. (ed.)
|
Academic Article
|
A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.
|
Academic Article
|
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.
|
Academic Article
|
The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites.
|
Academic Article
|
Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
|
Academic Article
|
Review and Consensus on Pharmacogenomic Testing in Psychiatry.
|
Academic Article
|
Ontogeny of Scaling Factors for Pediatric Physiology-Based Pharmacokinetic Modeling and Simulation: Microsomal Protein Per Gram of Liver.
|
Academic Article
|
Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy.
|
Academic Article
|
Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life.
|
Academic Article
|
Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism.
|